Parabilis Medicines, Inc. (PBLS) News
Track canonical SquawkNews coverage tagged to PBLS, Parabilis Medicines, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Parabilis Medicines reports Q2 2026 financial results, business updates
Parabilis Medicines (PBLS) reports its second-quarter 2026 financial results and provides accompanying business updates.
EARNINGS | Aug 13, 2026, 11:01 AM UTC
L
This Parabilis Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Evercore ISI Grou
EQUITY | Jul 06, 2026, 11:11 AM UTC
L
Buy Recommendation Issued On PBLS By Guggenheim
2026-07-06 03:15:02 ET Guggenheim analyst issues BUY recommendation for PBLS on July 6, 2026 06:39AM ET. <
EQUITY | Jul 06, 2026, 07:15 AM UTC